The parathyroid calcium-sensing receptor (CaR) plays a nonredundant role in systemic calcium homeostasis. In bone, Ca o resulting in hypercalcemia. Therefore, during bone remodeling, it is likely that the bone-forming osteoblasts (OBs), via the calcium-sensing receptor (CaR) (2), sense high Ca 2ϩ o generated within the immediate microenvironment of resorbing osteoclasts (OCs). In fact, high Ca 2ϩ o induces chemotaxis of human peripheral blood monocytes (3) and induces both chemotaxis and proliferation of mouse stromal cells (ST2) (4) and osteoblastic MC3T3-E1 cells (5). These cell types, respectively, have the capacity to differentiate into mature OCs (6) and OBs (7) under appropriate culture conditions.
. Indeed, certain malignancies that metastasize to bone promote uncontrolled release of skeletal Ca 2ϩ o resulting in hypercalcemia. Therefore, during bone remodeling, it is likely that the bone-forming osteoblasts (OBs), via the calcium-sensing receptor (CaR) (2) , sense high Ca 2ϩ o generated within the immediate microenvironment of resorbing osteoclasts (OCs). In fact, high Ca 2ϩ o induces chemotaxis of human peripheral blood monocytes (3) and induces both chemotaxis and proliferation of mouse stromal cells (ST2) (4) and osteoblastic MC3T3-E1 cells (5) . These cell types, respectively, have the capacity to differentiate into mature OCs (6) and OBs (7) under appropriate culture conditions.
OBs are mesenchymal-derived cells. Other mesenchymalderived cells known to express a functional CaR include fibroblasts (8) and chondrocytes (9) . However, studies of a murine preosteoblast (MC3T3-E1) cell line (5, 10) and human OB-like (MG-63) cells (11, 12) have yielded conflicting results regarding the molecular nature of the CaR that they express. Such discrepancies are not unusual given the reported phenotypic switch in MC3T3-E1 cells that may occur during cell passage (13, 14) and the incomplete resemblance between MG-63 cells and actual OBs at the level of gene expression (15) . The existence of species-specific variation in CaR expression has also been reported. For example, murine OBs do not appear to express the CaR cloned from parathyroid/kidney (16, 17) but rather use an EF hand-containing calcium-binding protein, calcyclin, for Ca 2ϩ o -sensing (18) ; CaR-like immunoreactivity has been shown in OBs of bovine and rat bone sections (19) . However, expression of calcyclin and /or other EF hand proteins do not necessarily preclude, expression of a CaR in OB cells, similar to that expressed in parathyroid/kidney. For example, calcium-binding proteins belonging to the superfamily of EF-hand proteins are abundantly expressed in neuron (for review, see Ref. 20 ) and yet, a CaR similar to that in parathyroid and kidney has been cloned from rat striatum and localized in nerve terminals (21) . In addition, accumulating evidence suggest that Ca 2ϩ o acts as a major extracellular factor generated during bone remodeling, inducing the action of OBs while inhibiting those of OCs (3) . Therefore, determining the molecular target and mode of action of Ca 2ϩ o deserves careful study, because it might hold the potential for developing an anabolic therapy for states of bone loss.
With this as background, we used rat calvarial cells to investigate the molecular nature and function of the CaR expressed in bona fide osteoblasts. We found that the CaR expressed in the parathyroid (2) and kidney (22) is also expressed in calvarial OBs where it induces proliferation via the activation of stress-activated protein kinase (SAPK)/Jun-terminal kinase (JNK) pathway and up-regulation of c-fos, egr-1 (early growth response-1), and cyclin D genes.
Materials and Methods Materials
All routine culture media were obtained from Invitrogen Life Technologies (Grand Island, NY). Collagenase P and the bromodeoxyuridine (BrdU) proliferation kit were from Roche (Indianapolis, IN); the supersignal, enhanced chemiluminescence kit was from Pierce (Rockford, IL); protease inhibitors were from Roche; and other reagents were purchased from Sigma Chemical (St. Louis, MO).
Calvarial OB cultures
For each experiment, about 25-30 calvariae were harvested at room temperature from 21-d fetal rats (Sprague Dawley). Humane handling of rats was carried out according to the guidelines of the Center for Animal Resources & Comparative Medicine of Harvard Medical School. A previously described method of repeated digestion of the calvariae with 0.05% trypsin and 0.1% collagenase P (23) was used to release cells. After discarding the cells from the first two digestions, cells from next three digestions were pooled and cultured in DMEM containing 10% heat-inactivated FBS and 1% penicillin-streptomycin in 5% CO 2 at 37 C. For immunocytochemical determination of the CaR, cells were placed directly on coverslips. For the proliferation assay and Western blot analysis, cells were plated on 96-and six-well plates, respectively. For preparing RNA, cells were plated in 75-cm 2 flasks. After 3 d of culture, cells were serum starved in DMEM (0.5 mm Ca 2ϩ , 4 mm l-glutamine, 1% penicillin-streptomycin, and 0.2% BSA) for 4 h before any experiments. All experiments were done within 7 d after beginning the culture.
Gene delivery by recombinant adeno-associated virus (rAAV)
High-efficiency gene transfer into OB cells was accomplished using a rAAV-based method as described previously (24) . Both the human CaR sequence with a naturally occurring, dominant-negative mutation (R185Q) (25, 26) and the same vector containing the cDNA for the ␤-gal protein (referred to hereafter as BG) were under the control of a cytomegalovirus immediate-early (CMV-IE) promoter element and packaged as described previously. The BG served as the control for any nonspecific effects of rAAV infection. Cells were seeded (500 cells/well) in 96-well plates in 0.1 ml of growth medium and cultured overnight. About 1000-virus particles/cell (as optimized by pilot studies) were used to infect each well.
Immunoperoxidase and immunofluorescence
Cells cultured on coverslips for 3 d were fixed with 4% formaldehyde. After blocking endogenous peroxidase, cells were incubated in parallel with 5 g/ml mouse monoclonal anti-CaR antibody LRG (raised to amino acids 374 -391 in the human CaR) and affinity-purified anti-CaR antibody 4637 (raised to amino acids 344 -358 in the human CaR) (27-29). Negative controls were carried out by incubating the cells with the respective antisera after they had been preabsorbed with 10 g/ml of the specific peptide to which each had been raised. After washing of cells incubated with the primary antibodies, appropriate incubations with secondary antibodies were carried out and the color reaction was developed with the 3-amino-9-ethyl-carbazole substrate system (Dako, Carpinteria, CA).
Two-color immunofluorescence to detect CaR-and cbfa-1-positive cells (thus osteoblastic) was performed with monoclonal anti-CaR LRG antibody (peptide sequence used to raise this antibody was LRGHEESGDRFSNS-STAF) and polyclonal cbfa-1 antibody as previously described (27, 28).
Alexa Fluor 488 conjugated to goat antimouse secondary antibody was used for the CaR and Alexa Fluor 546 conjugated to goat antirabbit secondary antibody was used for cbfa-1 (the Alexa antibodies were both from Molecular Probes, Eugene, OR). Fluorescence images were collected with a Zeiss LSM 510 Meta Confocal microscope (Jena, Germany) at Harvard Center for Neurodegeneration and Repair (see Acknowledgments). Alexa 546 was excited at 546 nm, which produces a red signal, whereas fluorescein and Alexa 488 was excited at 488 nm, which yields a green signal. The autofluorescence of the samples was minimal and was subtracted from the values obtained during measurements. Because peptide blocking of LRG antibody was performed for both immunoperoxidase staining and Western blotting to establish its specificity, this control was not repeated in the studies using immunofluorescence.
Western analysis
Dispersed bovine parathyroid cells or confluent monolayers of HEKCaR or calvarial OB cells that had been cultured in six-well plastic cluster plates were rinsed with ice-cold PBS and scraped on ice into lysis buffer that contained 10 mm Tris-HCl (pH 7.4), 1 mm EGTA, 1 mm EDTA, 0.25 m sucrose, 1% Triton X-100, 1 mm dithiothreitol, and a cocktail of protease inhibitors (10 g/ml each of aprotinin, leupeptin, and calpain inhibitor as well as 100 g/ml Pefabloc). The cell lysates were then sonicated for 30 sec. Nuclei and cell debris were removed by centrifugation at 10,000 ϫ g for 10 min, and the resultant total cellular lysate in the supernatant was used either directly for SDS-PAGE or stored at Ϫ80 C.
Immunoblot analysis was performed essentially as described previously (12) . Aliquots of supernatant fractions containing the total cellular lysate (20 g of protein from HEKCaR and bovine parathyroid cells and 40 g from calvarial OB cells) were mixed with an equal volume of 2ϫ SDS-Laemmli gel loading buffer containing 100 mm dithiothreitol (DTT), incubated at 65 C for 30 min, and resolved electrophoretically on 6.5% acrylamide gels. The separated proteins were then transferred to nitrocellulose filters (Schleicher and Schuell, Keene, NH) and incubated with blocking solution (PBS with 0.25% Triton X-100 and 5% dry milk) for 1 h at room temperature. The blots were subsequently incubated overnight at 4 C with affinity-purified polyclonal antiserum 4637 at 1 g/ml with or without preincubation with twice the concentration (e.g. 2 g/ml) of the peptide to which the antiserum had been raised (as a control for nonspecific binding) in blocking solution with 1% dry milk. The blots were subsequently washed five times with PBS that contained 1% Triton X-100 and 0.15% dry milk (washing solution) at room temperature for 10 min each. The blots were further incubated with a 1:2000 dilution of horseradish peroxidase-coupled goat antirabbit IgG (Sigma) in PBS containing 1% Triton X-100 for 1 h at room temperature. The blots were then washed five times with the washing solution, and bands were visualized by chemiluminescence according to the manufacturer's protocol (Supersignal, Pierce Chemical).
Immunoprecipitation
Cell lysates from HEKCaR and calvarial OBs prepared as described above were centrifuged at 10,000 ϫ g for 10 min. Supernatant protein (500 g total lysate) was incubated with monoclonal LRG anti-CaR antibody overnight at 4 C. Protein A/G-agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA) were then added for an additional 1 h at 4 C. Bound immunocomplexes were washed three times with immunoprecipitation buffer, and the pellet was eluted by boiling with 2ϫ Laemmli sample buffer without DTT. After SDS-PAGE, Western analysis was performed, as described above, using affinity-purified polyclonal anti-CaR antibody 4637.
Kinase assay
For the determination of JNK phosphorylation, cells were harvested at 80 -90% confluence. After overnight culture in growth medium, cells were transfected with either dominant-negative CaR (DNCaR) or BG as described before using rAAV technology. Cells were then cultured for another 48 -72 h when protein expression of the transduced CaR was determined in pilot studies to be maximal. A previously described protocol for studying SEK-1 phosphorylation in H-500 Leydig tumor cells was modified and used to study JNK phosphorylation (24 
RT-PCR
Total RNA was prepared from 3-to 5-d-old cultures as described previously (30 -32). For RT-PCR analysis of the CaR mRNA, 2 g of total RNA were subjected to a one-step protocol according to the manufacturer's instructions (QIAGEN, Valencia, CA) using previously published primer pairs for the CaR that were derived from the RaKCaR sequence (22) . Table 1 shows the list of primers used for this purpose. The optimal temperature cycling protocol was determined to be 94 C for 30 sec, 56 C for 30 sec, and 72 C for 30 sec for 40 cycles with a programmable thermal cycler (PCR system 9700, Applied Biosystems). PCR products obtained in this manner were subjected to direct, bidirectional sequencing, employing the same primer pairs used for amplification of the products after purification of the respective DNA fragments from the PCRs with the QiaQuick kit (QIAGEN).
Northern analysis
The CaR transcript was determined using 2.5 g poly(Aϩ) RNA from total calvaria, OBs digested from calvaria, or kidney (as a positive control). Expression of cyclin D1, D2, and D3 were determined using 15-g aliquots of total RNA. Northern hybridization for the CaR employed a 577-bp fragment corresponding to nucleotides 721-1298 of the rat kidney CaR, RaKCaR (22) , which has been used extensively in our earlier studies (30 -32). 1.3-, 1.2-, and 1.7-kb cyclin D1, D2, and D3 cDNA fragments, respectively, were cut out of the pBluescript plasmid from their EcoRI cloning sites (generously provided by Dr. C. J. Sherr, St. Jude Children's Research Hospital, Memphis, TN) and were used for Northern analysis. After high-stringency hybridization and washing, 32 P-labeled radioactive bands were analyzed in a Typhoon 9410 Variable mode Imager (Amersham Biosciences Corp., Piscataway, NJ) using the ImageQuant program.
Quantitative real-time PCR
SYBR green chemistry was used to perform quantitative determination of CaR, IGF-I, c-fos, egr-1, and the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA following an optimized protocol described before (33). The design of sense and antisense oligonucleotide primers was based on published cDNA sequences using the Primer Express version 2.0.0 (Applied Biosystems, Foster City, CA). Primer sequences are listed in Table 1 . cDNA was synthesized with the Omniscript Reverse Transcription Kit (QIAGEN) using 2 g of total RNA in a 20-l reaction volume. For real-time PCR, the cDNA was amplified using an ABI PRISM 7000 Sequence Detection System (PE Applied Biosystems, Foster City, CA). The double-stranded DNA-specific dye SYBR Green I was incorporated into the PCR buffer QuantiTech SYBR PCR (QIAGEN) to allow for quantitative detection of the PCR product in a 25-l reaction volume. The temperature profile of the reaction was 95 C for 15 min, 40 cycles of denaturation at 94 C for 15 sec, annealing, and extension at 60 C for 1 min. An internal housekeeping control gene, GAPDH, was used to normalize differences in RNA isolation, RNA degradation, and the efficiencies of the reverse transcription. The size of the PCR product was first verified on a 1.5% agarose gel, followed thereafter by melting-curve analysis.
Proliferation assay
Subconfluent calvarial OB cells on 96-well plates were serum starved for 4 h in Ca 2ϩ -free DMEM containing 4 mm l-glutamine, 0.2% BSA, and 0.5 mm CaCl 2 . Cells were then stimulated in the same medium with various concentrations of Ca 2ϩ (0.5-7.5 mm) for 18 h. Cell proliferation was measured using the BrdU ELISA from Roche according to the manufacturer's instructions. For the last 3 h of the 18-h stimulation period, the cells were pulsed with BrdU. Absorbance at 450 nm was measured with a microplate reader (Model 550, Bio-Rad, Hercules, CA).
Statistics
The data are presented as the mean Ϯ se of the indicated number of experiments. Data were analyzed by one-way ANOVA followed by Dunnett's multiple comparison test or Student's t test when appropriate. P Ͻ 0.05 indicates a statistically significant difference.
TABLE 1. Sequence of the primers used in this study and their accession numbers
Name and accession number of the genes Sequence (5Ј-3Ј)
GCACTCTGCTTGCTCACCTTTA ( 
Results

Immunoreactivity of CaR protein in calvarial OBs with CaR-specific antibodies
We first determined the specificity of the two antibodies used in this study: the monoclonal (LRG) and the affinitypurified polyclonal (4637) antibodies. These studies employed cells derived from calvaria that were greater than 90% alkaline phosphatase (ALP) positive. Figure 1A shows strong immunocytochemical staining of the CaR with monoclonal LRG and elimination of the staining after preincubation of the antibody with the peptide to which it was raised (Fig. 1B) . The 4637 antibody also stained CaR protein but to a lesser extent (Fig. 1C) . However, the staining with 4637 was specific as revealed by the abolition of staining upon preincubating the antibody with the peptide (FF7) against which it was raised (Fig. 1D) .
These data allowed us to use monoclonal LRG for assessing colocalization of the CaR with cbfa-1 (Runx2) for which a polyclonal antibody is available. As shown by confocal microscopy (Fig. 2 , A-C), CaR immunoreactivity (green) could be seen in cbfa-1-positive cells (red). These two colors do not merge, indicating that they stain structures in different cellular compartments; however, it is clear that the CaR is expressed in preosteoblasts. Interestingly, confocal microscopy of the CaR staining revealed a staining pattern that is both cytosolic (perinuclear) as well as on the cell surface, whereas light microscopic assessment showed predominantly cell surface staining (Fig. 1) . This is because of the limitations of sensitivity and magnification of light microscopy, as we have observed previously for both perinuclear and cell surface immunostaining of the CaR in MG-63 osteosarcoma cells by confocal microscopy (12) . In addition, immunostaining similar to that observed in OB-derived cells has also been demonstrated in other cell types, such as primary oligodendrocyte (32) and microglia (31). The cytosolic immunostaining may reflect the presence of specific CaR immunoreactivity in immature CaR proteins undergoing posttranslational modification.
We further characterized the CaR protein by Western blot analysis of the highly enriched OB population having CaR immunoreactivity. In the simple Western blot, the whole-cell lysate from rat primary osteoblasts showed strong immunoreactive bands with the 4637 anti-CaR antibody between 126 and 218 kDa (Fig. 3) . These signals disappeared when the antibody was preincubated with the specific blocking peptide (Fig. 3A, lane 2) . To confirm the specificity further, we performed immunoprecipitation with mouse LRG anti-CaR antibody and then blotted with rabbit 4637 anti-CaR antibody, which recognizes a different epitope of the CaR (Fig. 3B) . At least two bands were detected around 140 and 160 kDa that are comparable to the those in extracts of bovine parathyroid glands (Fig. 3B, lane 2) . The uppermost band (indicated by arrowhead) in rat primary OBs (Fig. 3B, lane 3) , corresponds to that of HEK cells stably transfected with the CaR in lane 1 (Fig.  3B) , which is most likely the dimerized form of the CaR owing to the use of nonreducing conditions during sample preparation. These results suggest that a substantial amount of CaR similar to that of human parathyroid gland is expressed in rat calvarial OBs. amplified a cDNA product of the expected length (383 bp). Sequencing revealed 100% homology with the corresponding segment of RaKCaR. In addition, use of primer pairs encompassing the putative extracellular, transmembrane, and intracellular domains of RaKCaR yielded DNA fragments of 480, 361, and 331 bp (lanes 3-5). These data suggest that calvarial OBs express a full-length CaR similar to that cloned from rat kidney. Therefore, we assessed the sizes of the CaR transcripts expressed in calvaria and in OBs obtained from calvarial digests by Northern blot analysis (Fig. 4B) . A cRNA probe revealed the expression of a 4.1-kb band similar to those of stomach and microglia (30, 31).
Detection of CaR mRNA in calvarial OBs by RT-PCR and Northern blot analysis
Temporal expression of CaR mRNA in OB culture
Loss of CaR gene expression has been documented in parathyroid cells in culture (34). Therefore, to ensure that the CaR is expressed in calvarial OBs in culture, we studied the temporal expression of the CaR by real-time PCR. This study also helped us to time the functional experiments to be described subsequently. Given the rapid doubling time of these cells and their capacity to attain 100% confluency within 5-7 d from an initial seeding density of 30% (pilot study, data not shown), we selected the window of d 3-7 after setting up the primary digests of the calvaria for studying expression of the CaR gene. Because real-time determination of transcripts by SYBR green chemistry requires a cDNA product no larger than 150 bp, we had to use primer pairs for the CaR that were different from those used for RT-PCR amplification of CaR mRNA in calvarial OBs. The designed primer pair yielded a single cDNA product as assessed by melting-curve analysis and by running the product in 2% agarose gel (data not shown). Using 2 g of total RNA for the reverse transcriptase (Fig. 5B) .
High Ca 2ϩ o up-regulates c-fos, egr-1, and cyclin D genes in calvarial OBs
Understanding proto-oncogene activation and characterizing signal transduction mechanisms are key to evaluating the control of cellular proliferation. Because calvarial OBs comprise a highly proliferative preosteoblastic population of cells, we considered it reasonable to test whether high Ca (Fig. 6) . Figure 6A We also studied the cyclin D genes, which act as a fundamental link between mitogenesis and the cell-cycle machinery, particularly during the G1 phase of the cell cycle (38) and high calcium down-regulates it in parathyroid cells (39) . Calvarial OBs were harvested directly after collagenase digestion of calvaria and plated in 10-cm 2 dishes at 40 -50% confluency. They were cultured for 5 d or allowed to reach approximately 80% confluence before the cells were serum-starved for 4 h in low Ca 2ϩ medium (DMEM containing 0.5 mm Ca 2ϩ , 4 mm l-glutamine, 1% penicillin-streptomycin, and freshly added 0.2% BSA from 5% stock). This medium was replaced with the same medium containing 0.5 and 5.0 mm Ca (Fig. 7A) . Densitometric analysis shows quantitative assessment of the increases in expression of the cyclin D genes by elevated Ca 2ϩ o in arbitrary units (Fig. 7B) .
High Ca 2ϩ o induces proliferation of calvarial OBs but not IGF-I mRNA
Because induction of c-fos, egr-1, and cyclin D genes indicates initiation of cellular proliferation, we assessed the possible mitogenic action of high Ca (Fig. 8B) .
High Ca 2ϩ o -induced proliferation of calvarial OBs is CaR mediated
Using calvarial digests without any passaging, we next tested whether the CaR mediated high Ca liferation. We introduced the human DNCaR-(R185Q) or BG into these cells using rAAV as the delivery system. Whereas the proliferative response induced by high Ca 2ϩ o was retained in cells transduced with BG, it was significantly attenuated in cells with DNCaR (Fig. 9) . Such attenuation is not a nonspecific event because DNCaR cells were still responsive to BMP-2-induced proliferation (Fig. 9) . These data confirm that the CaR mediates the proliferation induced by high Ca 
CaR-induced proliferation requires activation of JNK pathway
To gain insight into the signal transduction cascades activated during the CaR-stimulated proliferation, we screened the effects of various inhibitors of different MAPKs and stress-activated kinases in pilot studies (data not shown). We observed complete obliteration of high Ca (Fig. 10) .
CaR induces phosphorylation of JNK
Accordingly, we found that activation of the CaR by the addition of 5.0 mm Ca 2ϩ o caused a time-dependent increase in the intensity of the immunoreactivity of the phospho-JNK band at the 5-and 15-min time points (Fig. 11) . To confirm that this high Ca containing the JNK inhibitor SP600125 (10 M), and the BrdU incorporation assay was performed as described previously. SP600125 (10 M) had no effect on the basal state of proliferation but reduced high Ca ϩ 50 ng/ml BMP-2 in serum-free medium and incubation for 16 h. The remainder of the experiment was similar to that described in Fig. 7 . *, Significantly greater than 0.5 mM Ca 2ϩ ; **, significantly greater than 2.5 mM Ca 2ϩ . P Ͻ 0.05; n ϭ 4.
used the ␤-gal containing empty vector as control. Figure 11 shows significant attenuation of the phospho-JNK signal in dominant-negative infected cells incubated with 5.0 mm Ca 2ϩ o compared with BG-infected cells. Because the DNCaR inhibits the high calcium-induced increase in JNK activity, it is very unlikely that the changes seen at high calcium are nonspecific effects due to temperature/handling in BGinfected cells. Pooled data from three independent experiments where p-JNK bands were determined by densitometry and normalized with t-JNK band intensity and expressed in arbitrary units (P Ͻ 0.05) (Fig. 11, lower panel) . Densitometric quantitation shows an approximately 44% attenuation of the phospho-JNK signal in the DNCaR infected cells compared with the BG-infected control cells.
Discussion
In this report, we show the physical presence and functional role of the CaR in calvarial OBs. Bone formation by OBs involves several sequential steps, whereby there is proliferation of preosteoblasts and their recruitment by chemotaxis to sites of eventual bone formation, followed by their differentiation to mature, bone-forming OBs that ultimately mineralize bone. If the end point of bone formation is mineralization, the availability of bone-forming cells through the proliferation of preosteoblasts is crucial. Known growth factors of both systemic and local origins, e.g. BMP-2, IGF-I, and FGF, exert mitogenic effects on OBs (41) . Ca 2ϩ o is one of the major extracellular factors generated in large concentrations in the local bony microenvironment, especially during the resorptive phase of bone remodeling (1). It is, therefore, conceivable that during this phase, a locally high level of Ca 2ϩ o could act on its cognate receptor, the CaR, to promote some of the steps involved in generating bone-forming OBs.
To date, our laboratory and others have shown that an elevated level of Ca 2ϩ o promotes OB proliferation and chemotaxis (5, 10) . However, the molecular basis for these actions is contentious, given the reported inconsistency in documenting the expression of a CaR in OBs similar to that in parathyroid and kidney (10, 11) . An important factor contributing to this inconsistency may be the osteoblastic cell lines that have been used for these studies. MC3T3-E1 cells (5, 10) are known to undergo a phenotypic switch over a number of passages (13, 14) and are not readily available (e.g. not obtainable through the ATCC). Furthermore, MG-63 cells (11, 12) don't completely resemble their normal OB counterpart with regard to gene expression and other patterns of cytokine/growth factor responses (15) . Furthermore, species variation in its expression could also contribute, as expression of the CaR was undetectable in mouse osteoblasts (16) . Furthermore, osteoblasts from the rescued, CaR-deficient mouse, which lack of a bone phenotype, function normally in their response to Ca 2ϩ o in vitro (42) . However, expression of the CaR has been documented in osteoblasts of bovine tibia and rat femur by in situ hybridization (18) . Moreover, using the type II CaR agonist in organ culture (fetal rat metatarsal bones) for bone growth, Wu et al. (43) showed that CaR regulates growth plate chondrogenesis and longitudinal bone growth. In addition, CaR knockout mouse bone showed rickets, not a phenotype expected with hyperparathyroidism (17) . Therefore, we have pursued these observations in rat calvarial OBs and determined its molecular nature and showed that it regulates cellular proliferation of calvarial OBs, which appear to be mediated by the parathyroid CaR, i.e. through use of the DNCaR (R185Q) (25, 26) .
We obtained an approximately 90% pure population of osteoblastic cells, as assessed by ALP staining (data not shown), from the primary digests of calvariae. Well-characterized antibodies raised to two different regions of the CaR protein showed specific immunoreactivity in these cells. In addition, immunoreactivity of the CaR in cbfa-1-positive cells was observed with an immunofluorescent detection method combined with confocal microscopy. Interestingly, functional expression of the CaR has been found in ameloblast cells and developing tooth organ (44, 45) , which express cbfa-1 (46) and regulate the production, resorption, and degradation of enamel matrix as well as the transport of Ca 2ϩ into the extracellular matrix.
Western analysis with affinity-purified antibody 4637 showed labeling of bands of sizes consistent with CaR monomers and dimers with varying degrees of glycosylation, based on their being similar or identical in size to the corresponding bands in extracts of bovine parathyroid glands labeled with the same antibody. The specificity of the antibody was demonstrated by the elimination of these bands after preincubation of the antibody with the peptide to which it was raised. To provide additional evidence for the presence of the CaR in calvarial OBs, we performed immunoprecipitation with anti-CaR antiserum LRG (monoclonal) and then subjected the immunoprecipitate to Western blotting using anti-CaR antiserum 4637. Because these two antibodies were raised to two different epitopes of the CaR protein, the presence of labeled bands obtained from cal- varial OB that are comparable in size to those of the CaR in parathyroid cells provides additional evidence for its expression in OBs.
Use of nucleotide-based approach such as RT-PCR and Northern analysis revealed expression of a CaR gene that is similar to the one expressed in rat kidney. A combination of intron-spanning primers representing the extracellular domain of RaKCaR and primer pairs representing transmembrane and intracellular domains amplified cDNA products identical with the corresponding segments of RaKCaR. These data strongly suggest that calvarial OBs express a CaR gene similar to that previously cloned from rat kidney (22) and striatum (21) . Highstringency Northern analysis with a cRNA probe for RaKCaR revealed a 4.1-kb band in both whole calvaria and calvarial OBs. A differential pattern of expression of CaR transcripts has been reported in various rat/mouse tissues and cell types (30 -32, 47, 48) . Expression of only a 4.1-kb band has been reported in stomach and microglia (30, 31), whereas in the duodenum, the 4.1-kb transcript is much more abundantly expressed than is the 7.5-kb transcript (30). Although the physiological significance of such cell type-specific expression of CaR transcript(s) is presently unknown, the 4.1-kb transcript that is expressed in OBs encodes the entire functional CaR protein (22) .
These results provide irrefutable evidence that calvarial OBs express a CaR that is similar to the CaR previously cloned from rat kidney and brain. Furthermore, unlike parathyroid cells, which lose expression of the CaR in vitro (34), expression of the CaR is retained in cultures of calvarial OBs and is up-regulated as a function of time. Possible reasons for the increased CaR expression might include increased confluency and increased secretion of autocrine factor(s): however, ascertaining the reason(s) for this temporal increase is beyond the scope of this report. Our data on the temporal increase in CaR gene expression in culture allowed us to use a window of 5-7 d post harvesting to perform functional studies. In addition, CaR expression did not differ between low (0.5 mm) and high (5.0 mm) Ca 2ϩ o , suggesting that CaR expression does not undergo ligand-induced alteration. These data are useful for optimizing conditions for carrying out studies on the functional impact of activation of the CaR in OBs.
Calvarial OBs derived from a fetal/neonatal source are predominantly highly proliferative preosteoblastic cells. Numerous lines of evidence suggest that c-fos may be involved in several aspects of OB function, such as proliferation, differentiation, and ultimately bone formation (49 -51) . The c-fos has been shown to be expressed in regions of fetal bone having the highest growth potential (35) and is regulated in vitro and in vivo by PTH (1-34) (52, 53) . In addition, c-fos-deficient mice develop osteoporosis and lack osteoclasts (54, 55) , which provide compelling evidence for its role in OB function. Egr-1, a nuclear Zn 2ϩ finger protein and transcriptional regulator, was shown to be coregulated with c-fos in developing mouse organs and has an overlapping pattern of expression in mesenchymally derived cells at sites of ossification (36, 37) . Therefore, we investigated whether high Ca 2ϩ o , possibly acting via the CaR, regulates these proto-oncogenes. We observed a rapid induction in the expression of these genes by high Ca 2ϩ o , consistent with previously published rapid activation in response to PTH (51) and PGI 2 (37) . An interesting feature of the time course of high Ca (24) , which could then act in an autocrine manner to induce c-fos expression (52) . Thus, it is conceivable that the CaR might exert PTH-like effects in OB cells.
In addition, proliferation of mammalian cells is strictly regulated by extracellular signals, which exert their effects on cells primarily during the G1 phase of the cell cycle and regulate progression to the S-phase. D-type cyclins are some of the major mediators of the G1-S-phase progression, serving as targets of growth factors that integrate extracellular signals into the core cell-cycle regulators (38) . Because high Ca (24, 57) . Therefore, the molecular nature of the CaR displayed by calvarial osteoblasts in this study is functionally consistent with that of the cloned G protein-coupled CaR from rat kidney (22) that is homologous with parathyroid CaR (2) .
Interesting in this regard is the failure of high Ca 2ϩ o to stimulate IGF-I mRNA in these cells. IGF-I is a potent mitogen for OBs, and PTH stimulates its secretion (58) . The report of abolition of high Ca 2ϩ o -induced proliferation of MC3T3-E1 cells, a mouse osteoblastic cell line, by IGF-I-neutralizing antibody suggests a mediatory role of IGF-I in this process (40) , whereas such a role for IGF-I was not found in the rat osteoblast like cell line, PyMS (59) . However, the report using PyMS cells used concentrations of Ca 2ϩ between 0.2 and 1.0 mm, well below those generally used to activate the CaR, and the effect of Ca 2ϩ on DNA synthesis was blocked by nifedipine, a L-type channel blocker. In our study, we not only found no change in IGF-I mRNA level in response to high Ca 2ϩ (5.0 mm) but also observed that IGF-I expression level is extremely low as assessed by real-time PCR.
IGF-I expression by osteoblastic cells is a controversial issue, with evidence both for (60 -62) and against (63-65) its expression. Our method of assessing IGF-I expression by real-time RT-PCR indicates a low copy number in calvarial OBs because of the very late appearance of the PCR product, which was unchanged by high Ca 2ϩ o . Therefore, our data suggest that CaR-induced proliferation of calvarial OB is independent of IGF-I.
Induction of proliferation by the CaR has been shown in variety of cell types including fibroblasts (8) , ovarian surface epithelial cells (66) , H-500 Leydig tumor cells (67) , and CaRtransfected CCL3 hamster fibroblasts (which lack endogenous CaR expression) (68) . CaR-induced proliferation involves a diverse array of signaling pathways (for review see Ref. In conclusion, our study reveals expression of a kidney/ parathyroid CaR in rat calvarial osteoblasts, which promotes mitogenesis in these cells. 
